Merck’s investigational antibody MK-2214 has received fast-track designation from the FDA for the treatment of Alzheimer’s disease. MK-2214 targets phosphorylated serine 413 tau (pS413), a marker of ...

Did you know weak leg muscles accelerate cognitive decline & dementia risk after 40? Learn how to strengthen legs for better ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

Semaglutide, the drug behind weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline among people with ...

Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and ...

A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the ...

Investing.com -- ProMIS Neurosciences Inc (NASDAQ:PMN) stock climbed 6% on Monday following the publication of research supporting the company’s biomarker-driven approach to Alzheimer’s disease ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

Americans are more likely to visit their eye doctor than their primary care provider. And that’s one big reason why a company out of California is working with Banner Alzheimer’s Institute in Arizona ...

Evidence increasingly shows that chronic exposure to PM2.5, a neurotoxin, not only damages lungs and hearts but is also ...

There is increasing evidence that chronic exposure to PM2.5, a neurotoxin, not only damages lungs and hearts but is also ...